Tizanidne Hydrochloride Capsule
Product Images NDC 63629-8872

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 63629-8872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298872)

This is the description of Tizanidine Hydrochloride Capsules. Each capsule contains 4.58 mg tizanidine hydrochloride equivalent to 4 mg tizanidine base. It is important to keep the medication in a tight container and out of the reach of children. The medication should be stored at 25°C (77°F). This medication is not interchangeable with tizanidine tablets or Zanaflex® tablets. The NDC number for this medication is 63629-8872-1.*

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

This text describes the improvement in Ashworth score with the use of Tizanidine, with a mean dose of 26.8 mg. The study lasted for 7 weeks, with the endpoint being the last observation carried forward. It also indicates a titration period that ended on the third week of the study.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.